Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Senti Biosciences (SNTI)
NASDAQ:SNTI
Senti Biosciences (SNTI) Stock Price & Analysis
61 Followers
SNTI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.27 - $1.22
Previous Close$0.29
Volume49.18K
Average Volume (3M)83.02K
Market Cap
$13.27M
Enterprise Value$15.01M
Total Cash (Recent Filing)$35.93M
Total Debt (Recent Filing)$37.67M
Price to Earnings (P/E)-0.2
Beta1.98
Next Earnings
May 07, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.60
Shares Outstanding45,755,021
10 Day Avg. Volume67,696
30 Day Avg. Volume83,020
Standard Deviation0.28
R-Squared0.29
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)0.21
Price to Sales (P/S)4.32
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.66
Enterprise Value/Gross Profit5.86
Enterprise Value/Ebitda-0.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Senti Biosciences News
Ownership Overview
23.91% Insiders
7.90% Mutual Funds
8.57% Other Institutional Investors
59.61% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
SNTI FAQ
What was Senti Biosciences’s price range in the past 12 months?
Senti Biosciences lowest stock price was $0.27 and its highest was $1.22 in the past 12 months.
What is Senti Biosciences’s market cap?
Currently, no data Available
When is Senti Biosciences’s upcoming earnings report date?
Senti Biosciences’s upcoming earnings report date is May 07, 2024 which is in 17 days.
How were Senti Biosciences’s earnings last quarter?
Senti Biosciences released its earnings results on Mar 21, 2024. The company reported -$0.42 earnings per share for the quarter, the consensus estimate of -$0.42 by $0.
Is Senti Biosciences overvalued?
According to Wall Street analysts Senti Biosciences’s price is currently Overvalued.
Does Senti Biosciences pay dividends?
Senti Biosciences does not currently pay dividends.
What is Senti Biosciences’s EPS estimate?
Senti Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Senti Biosciences have?
Senti Biosciences has 45,755,020 shares outstanding.
What happened to Senti Biosciences’s price movement after its last earnings report?
Senti Biosciences reported an EPS of -$0.42 in its last earnings report, expectations of -$0.42. Following the earnings report the stock price went down -6.383%.
Which hedge fund is a major shareholder of Senti Biosciences?
Among the largest hedge funds holding Senti Biosciences’s share is ARK Investment Management LLC. It holds Senti Biosciences’s shares valued at 1M.
---
Senti Biosciences Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Increased
By 143.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 13.7%
Last 30 Days ▼ 13.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-69.00%
12-Months-Change
Fundamentals
Return on Equity
-95.50%
Trailing 12-Months
Asset Growth
-33.91%
Trailing 12-Months
Company Description
Senti Biosciences
Dynamics Special Purpose Corp is a blank check company.
---
SNTI Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Bioxcel Therapeutics
―
Intra-Cellular Therapies
―
Adverum Biotechnologies
―
Crispr Therapeutics AG
―
Best Analysts Covering SNTI
1 Year
1 Year Success Rate
0/5 ratings generated profit
1 Year Average Return
-70.98%
reiterated a buy rating 12 months ago
Copying Geulah Livshits's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -70.98% per trade.
---